Brian Rosenberger, VP, Commercial & Business Development at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 12,663 shares at $0.60 ($8K) on 2023-01-23, disclosed to the SEC on 2023-01-25.
Open-market sale of $8k ZYNE by VP, Commercial & Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |